News
12h
Mining Technology on MSNTariffs driving supply chain localisation and automationLocalising and automating supply chains will allow companies to mitigate the impact of tariffs and minimise resulting costs.
Following today’s release of DFS’ figures for the 52 weeks ending 29 June 2025; Matt Walton, senior retail analyst at ...
10d
Just Auto on MSNGovernment subsidies drive China’s vehicle market up – GlobalData"Government subsidies drive China’s vehicle market up – GlobalData" was originally created and published by Just Auto, a ...
2d
GlobalData on MSNCaranx Medical’s AI TAVI-TAVR software gains FDA approvalThe US Food and Drug Administration (FDA) has cleared Caranx Medical’s TAVIPILOT Soft, an artificial intelligence (AI)-based guide software for use during Transcatheter Aortic Valve Implantation (TAVI ...
(Alliance News) - GlobalData PLC on Tuesday said its process for move to London's Main Market away from the AIM Market is underway, as it highlighted continued investment in Growth Transformation Plan ...
Experian (EXPN), Barratt Redrow (BTRW), B&M European Value (BME), GlobalData (DATA), Robert Walters (RWA), Mobico (MCG), ...
Walmart and its banking partner Mastercard have created a new payment system for international money transfers, data ...
Artificial intelligence, robotics and the Internet of Things (IoT) are no longer futuristic concepts—they are reshaping how consumer brands operate, engage and grow. As these technologies move from ...
2d
Private Banker International on MSNKirkland & Ellis leads North American M&A legal Advisers in H1 2025Kirkland & Ellis has topped the legal adviser ranking in mergers and acquisitions (M&A) by value and volume in North America ...
6d
Air Force Technology on MSNDSET 2025: a tour of military simulation training systemsMany companies gathered in Bristol to showcase military simulation systems at the Defence Simulation, Education, and Training exhibition.
13d
Clinical Trials Arena on MSNNovartis’ Cosentyx shows no benefit in Phase III GCA trialNovartis’ Cosentyx (secukinumab) has failed to show any benefit in the Phase III study in adults with newly diagnosed or relapsing giant cell arteritis (GCA). In the GCAptAIN trial (NCT04930094), ...
3d
GlobalData on MSNKirkland & Ellis leads M&A legal advisory ranking in H1 2025Kirkland & Ellis has been identified as the leading legal adviser in mergers and acquisitions (M&A) for the first half of 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results